Cargando…
Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) is a tumor suppressor and its overexpression has been shown to exert anti-tumor effects as a therapeutic target gene in many human cancers. Recently, we demonstrated the anti-glioma effects of an adenoviral vector carrying REIC/Dkk-3 w...
Autores principales: | Hattori, Yasuhiko, Kurozumi, Kazuhiko, Otani, Yoshihiro, Uneda, Atsuhito, Tsuboi, Nobushige, Makino, Keigo, Hirano, Shuichiro, Fujii, Kentaro, Tomita, Yusuke, Oka, Tetsuo, Matsumoto, Yuji, Shimazu, Yosuke, Michiue, Hiroyuki, Kumon, Hiromi, Date, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409598/ https://www.ncbi.nlm.nih.gov/pubmed/36006934 http://dx.doi.org/10.1371/journal.pone.0273242 |
Ejemplares similares
-
ACT-15 AD-SGE-REIC GENE THERAPY FOR MALIGNANT GLIOMA
por: Kurozumi, Kazuhiko, et al.
Publicado: (2019) -
Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration
por: Uneda, Atsuhito, et al.
Publicado: (2021) -
Annexin A2–STAT3–Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma
por: Matsumoto, Yuji, et al.
Publicado: (2020) -
A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy
por: Oka, Tetsuo, et al.
Publicado: (2016) -
PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma
por: Otani, Yoshihiro, et al.
Publicado: (2017)